Abstract
Tonsil-derived mesenchymal stem cells (TMSC) have characteristics of MSC and have many advantages. In our previous studies, intraperitoneal (IP) injection of TMSC in acute and chronic colitis mouse models improved the disease activity index, colon length, and the expression levels of proinflammatory cytokines. However, TMSC were not observed to migrate to the inflammation site in the intestine. The aim of this study was to verify the therapeutic effect of conditioned medium (CM) released by TMSC (TMSC-CM) in a mouse model of dextran sulfate sodium (DSS)-induced chronic colitis. TMSC-CM was used after seeding 5×105 cells onto a 100 mm dish and culturing for 5-7 days. TMSC-CM was concentrated (TMSC-CM-conc) by three times using a 100 kDa cut-off centrifugal filter. Seven-week-old C57BL/6 mice were randomly assigned to the following 5 groups: 1) normal, 2) colitis, 3) TMSC, 4) TMSC-CM, and 5) TMSC-CM-conc. Chronic colitis was induced by continuous oral administration of 1.5% dextran sulfate sodium (DSS) for 5 days, followed by 5 additional days of tap water feeding. This cycle was repeated two more times (total 30 days). Phosphate buffered saline (in the colitis group), TMSC, TMSC-CM, and TMSC-CM-conc were injected via IP route 4, 4, 12, and 4 times, respectively. Reduction of disease activity index, weight gain, recovery of colon length, and decreased in the expression level of the proinflammatory cytokines, interleukin (IL)-1β, IL-6, and IL-17 were observed at day 30 in the treatment groups, compared to control. However, histological colitis scoring and the expression level of tumor necrosis factor α and IL-10 did not differ significantly between each group. TMSC-CM showed an equivalent effect to TMSC related to the improvement of inflammation in the chronic colitis mouse model. The data obtained support the use of TMSC-CM to treat inflammatory bowel disease without any cell transplantation.
Highlights
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease characterized by wax and wane inflammation
This study aimed to evaluate the therapeutic effect of the conditioned medium (CM) released by tonsil-derived mesenchymal stem cells (TMSC) (TMSC-CM) in dextran sulfate sodium (DSS)-induced chronic murine colitis models
Splenocytes stimulated by LPS or phorbol 12-myristate 13-acetate (PMA)/ionomycin showed a decreased proliferation rate when co-cultured with TMSC, and cultured in TMSC conditioned medium (TMSC-CM); the proliferation rates were 7.30 ± 0.43, 5.77 ± 0.56, 4.88 ± 0.80, 4.28 ± 0.22, 5.56 ± 0.18, and 4.45 ± 0.87 in LPS, LPS + 5×103 TMSC, LPS + 5×104 TMSC, LPS + 5×105 TMSC, LPS + TMSC-CM, and LPS + TMSC-CM-conc, respectively (p < 0.0001, Analysis of variance (ANOVA)); 6.49 ± 0.13, 4.71 ± 0.06, 4.34 ± 0.83, 4.30 ± 0.30, 2.27 ± 0.33, and 2.13 ± 0.47 (p < 0.0001, ANOVA) (Fig 2)
Summary
The aim of this study was to verify the therapeutic effect of conditioned medium (CM) released by TMSC (TMSC-CM) in a mouse model of dextran sulfate sodium (DSS)-induced chronic colitis. This study aimed to evaluate the therapeutic effect of the conditioned medium (CM) released by TMSC (TMSC-CM) in DSS-induced chronic murine colitis models
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
